This project represents the first assessment of Oral Medication (OM) adherence in patients with AML.
CareviveMay 14, 2020
Authors: Ashley Leak Bryant PhD, RN1 ; Ya-Ning Chan RN, MSN1 ; Jaime Richardson RN, BSN1; Matthew Foster, MD1 ; Debra Wujcik, PhD, RN2 1 The University of North Carolina at Chapel Hill School of Nursing; 2 North Carolina Cancer Hospital, Lineberger Comprehensive Cancer Center, Division of Hematology and Oncology, The University of North Carolina at Chapel Hill 3 Carevive…
CareviveMay 5, 2020
Authors: Debra Wujcik, PhD, RN1 ; Susie Owenby, RN1 ; Moh’d Khushman MD2 ; Daniel Cameron, MD2; Thomas Butler, MD2; Cathy Tinnea RN2, Austin Cadden MPH2, Jennifer Pierce, MD2, Sachin Gopalkrishna Pai, MD2 1 Carevive Systems, Inc, Miami, FL 2 University of South Alabama Mitchell Cancer Institute Background Treatment of lung cancer has seen a paradigm shift in recent years.…
CareviveMay 1, 2020
Carevive's Debra Wujcik, PhD, RN, AOCN, FAAN along with Jeannine M. Brant, PhD, AOCN, FAAN from Billings Clinic presented a poster at the 2019 MASCC/ISOO Annual Meeting titled "Tablet-Based Expanded Pain Assessment Reveals Severe Flares and End of Dose Pain at Home". Background Cancer pain prevalence is high (52%-77%) and includes pain flares and end-of-dose failure. Poorly controlled pain contributes…
CareviveJune 24, 2019
NOT FOR CME/CREDIT FOR REFERENCE ONLY Recorded On Thursday, December 6th, 2018 1:00 – 2:00 pm EST In 2018, there will be an estimated 164,690 new cases of prostate cancer (PC) in the U.S. and approximately 29,430 patients will die of the disease, making it the third-leading cause of cancer death in men (American Cancer Society , 2018). The majority…
CareviveDecember 7, 2018
Note: This on-demand video is not available for CME/CNE credit. Acute myeloid leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit patients treated with intensive chemotherapy…
CareviveJuly 25, 2018
Carevive’s Chief Clinical Officer and Co-Founder, Carrie Stricker, PhD, RN, is featured in video interviews from the ACCC 44th Annual Meeting & Cancer Center Business Summit that are now live on OBR’s video library. In these short videos, she talks about challenges practices are facing when implementing patient engagement, the importance of patient-reported outcomes, and solutions to drive better capture the patient symptom…
CareviveApril 12, 2018
As part of the AONN+ Mission & Vision Committee Workshop Meetings, Carevive’s Oncology Solutions Expert, Carrie S. Tilley, MS, ANP-BC, AOCNP, presented a talk in a Technology and Innovation Committee panel discussion titled “Technology Supporting Navigation”. The mission of the Technology and Innovation Committee is to focus on the use of technology to capture data/metrics for evaluation, improve quality in navigation, and…
CareviveDecember 7, 2017
The Carevive team along with investigators from City of Hope, Rochester University, University of Arizona, and Mt Sinai are presenting a poster at the 59th ASH annual meeting, "Impact of a Brief Touchscreen Based, Modified Geriatric Assessment (mGA) on the Care of Older Adults with Multiple Myeloma". The purpose of the study was to test the feasibility of conducting a…
CareviveNovember 27, 2017
Poster presenter: Monique Gary, DO - Grand View Surgical Associates The Carevive team along with investigators from Grandview Indiana University Hospital, and Jefferson Sidney Kimmel Cancer Center are presenting a poster at the 40thAnnual San Antonio Breast Cancer Symposium, titled "Improving Neoadjuvant Breast Cancer Therapy Rates Uptake with Education and Technology". A 2-part intervention was undertaken to improve adherence to…
CareviveNovember 27, 2017
